12.22.14
The U.S. Food and Drug Administration (FDA) has approved the MyLab Six ultrasound system from Esaote North America.
MyLab Six is a compact, ultrasound with a profile to improve ergonomics for sonographers scanning in a seated position and can be configured with a suite of applications, making it ideal for shared ultrasound services in busy clinical settings.
“Today’s practices need ultrasound systems that deliver high quality images across a broad spectrum of clinical applications,” said Larry Dentice, president and general manager of Esaote North America. “In their quest to deliver quality healthcare at an affordable cost, practices are continually evolving and MyLab Six can evolve with them.”
The modular application structure of MyLab Six gives practices the flexibility to configure their system with the clinical applications needed at time of purchase, then add more capabilities as their needs change or as they expand into new services, company bigwigs noted. Application packages range from cardiovascular and musculoskeletal to ob-gyn and general imaging. Each package provides full measurement and report capabilities uniquely suited to the specific application.
A full range of advanced, ergonomic transducers also is available to extend the clinical utility of MyLab Six.
MyLab Six is available with a choice of high-resolution wide screen monitors and a combination of ergonomics that include:
Esaote North America, headquartered in Indianapolis, Ind., is a provider of multi-disciplinary ultrasound and musculoskeletal MRI systems in the United States. Established in 1979, Esaote North America is part of Esaote Group, a provider of diagnostic medical equipment research, production and marketing.
MyLab Six is a compact, ultrasound with a profile to improve ergonomics for sonographers scanning in a seated position and can be configured with a suite of applications, making it ideal for shared ultrasound services in busy clinical settings.
“Today’s practices need ultrasound systems that deliver high quality images across a broad spectrum of clinical applications,” said Larry Dentice, president and general manager of Esaote North America. “In their quest to deliver quality healthcare at an affordable cost, practices are continually evolving and MyLab Six can evolve with them.”
The modular application structure of MyLab Six gives practices the flexibility to configure their system with the clinical applications needed at time of purchase, then add more capabilities as their needs change or as they expand into new services, company bigwigs noted. Application packages range from cardiovascular and musculoskeletal to ob-gyn and general imaging. Each package provides full measurement and report capabilities uniquely suited to the specific application.
A full range of advanced, ergonomic transducers also is available to extend the clinical utility of MyLab Six.
MyLab Six is available with a choice of high-resolution wide screen monitors and a combination of ergonomics that include:
- Angular ergonomics — system base and keyboard conform to sonographer angles as they scan in a seated position
- Quiet scanning — new cooling technology results in virtually silent exams for a better patient experience
- Appleprobe transducers — award-winning transducer designs proven to reduce sonographer stress
- Touchscreen operation — high resolution touch surface speeds exam setup and workflow
- Adjustable system height — adjustable keyboard and articulating monitor to optimize operation
Esaote North America, headquartered in Indianapolis, Ind., is a provider of multi-disciplinary ultrasound and musculoskeletal MRI systems in the United States. Established in 1979, Esaote North America is part of Esaote Group, a provider of diagnostic medical equipment research, production and marketing.